HBIO · Harvard Bioscience Inc
$6.10
+0.02 (+0.25%)
At close · Jul 27
Going-concern doubt
— cleared May 12, 2026
The latest filing states the doubt was alleviated.
“Management has evaluated the Company's ability to continue as a going concern under ASC 205-40 for the twelve months following the issuance of these financial statements and concluded that the conditions and events that initially raised substantial doubt have been alleviated and that substantial doubt does not exist as of the date of issuance.”View the 10-Q filed May 12, 2026
Market Cap
$27.06M
Shares
4.51M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.